Literature DB >> 35876597

Perception of testing for COVID-19 during the first wave of the pandemic in Slovakia with emphasis on population age groups.

Beáta Gavurová1, Martin Rigelský2.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the perception of the respondents in selected areas of testing for COVID-19 during the first waves of this disease with an emphasis on the age categories.
METHODS: The research sample consisted of 806 Slovak respondents and the collection of data took place in February 2021. The study examined six areas, of which five focused on the perception of testing and one area focused on examining the risk of population behaviour. All areas were examined in the first as well as in the last testing for COVID-19. In terms of age, we focused on 4 age categories: up to 24 years, 25-44 years, 45-59 years, and over 60 years. Data were obtained by online survey, using descriptive analysis and nonparametric analysis of differences.
RESULTS: The results of the analysis show that age is a socioeconomic characteristic that is of great importance for the creation and implementation of epidemiological processes and programmes and therefore epidemiologists should pay increased attention to it when creating prevention programmes. Younger people perceived testing more positively than older ones, even though the course of the disease caused by COVID-19 is much more severe in older people. The difference in the perception of testing between age categories was confirmed in the first as well as in the last test study. Respondents perceived the last test more negatively and thus they showed slightly riskier behaviour compared to the first test.
CONCLUSIONS: We perceive testing as an efficient way in the fight against pandemics generally, but we point out that testing should be well accomplished in a managerial way, otherwise testing can have a negative impact on society's confidence.

Entities:  

Keywords:  SARS-CoV-2 pandemic; age; behaviour; mass testing; social attitudes; testing experience

Mesh:

Year:  2022        PMID: 35876597     DOI: 10.21101/cejph.a7013

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.154


  17 in total

Review 1.  Value and Validity of Coronavirus Antibody Testing.

Authors:  Amit Mahajan; Laxmaiah Manchikanti
Journal:  Pain Physician       Date:  2020-08       Impact factor: 4.965

2.  Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.

Authors:  Jacqueline Dinnes; Jonathan J Deeks; Sarah Berhane; Melissa Taylor; Ada Adriano; Clare Davenport; Sabine Dittrich; Devy Emperador; Yemisi Takwoingi; Jane Cunningham; Sophie Beese; Julie Domen; Janine Dretzke; Lavinia Ferrante di Ruffano; Isobel M Harris; Malcolm J Price; Sian Taylor-Phillips; Lotty Hooft; Mariska Mg Leeflang; Matthew Df McInnes; René Spijker; Ann Van den Bruel
Journal:  Cochrane Database Syst Rev       Date:  2021-03-24

3.  Antibody tests for identification of current and past infection with SARS-CoV-2.

Authors:  Jonathan J Deeks; Jacqueline Dinnes; Yemisi Takwoingi; Clare Davenport; René Spijker; Sian Taylor-Phillips; Ada Adriano; Sophie Beese; Janine Dretzke; Lavinia Ferrante di Ruffano; Isobel M Harris; Malcolm J Price; Sabine Dittrich; Devy Emperador; Lotty Hooft; Mariska Mg Leeflang; Ann Van den Bruel
Journal:  Cochrane Database Syst Rev       Date:  2020-06-25

4.  Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand.

Authors:  Chutikarn Chaimayo; Bualan Kaewnaphan; Nattaya Tanlieng; Niracha Athipanyasilp; Rujipas Sirijatuphat; Methee Chayakulkeeree; Nasikarn Angkasekwinai; Ruengpung Sutthent; Nattawut Puangpunngam; Theerawoot Tharmviboonsri; Orawan Pongraweewan; Suebwong Chuthapisith; Yongyut Sirivatanauksorn; Wannee Kantakamalakul; Navin Horthongkham
Journal:  Virol J       Date:  2020-11-13       Impact factor: 4.099

5.  Local Community Response to Mass Asymptomatic COVID-19 Testing in Liverpool, England: Social Media Analysis.

Authors:  Charlotte Robin; Charles Symons; Holly Carter
Journal:  JMIR Form Res       Date:  2022-08-04

6.  Perceptions and Experiences of the University of Nottingham Pilot SARS-CoV-2 Asymptomatic Testing Service: A Mixed-Methods Study.

Authors:  Holly Blake; Jessica Corner; Cecilia Cirelli; Juliet Hassard; Lydia Briggs; Janet M Daly; Malcolm Bennett; Joseph G Chappell; Lucy Fairclough; C Patrick McClure; Alexander Tarr; Patrick Tighe; Alex Favier; William Irving; Jonathan Ball
Journal:  Int J Environ Res Public Health       Date:  2020-12-29       Impact factor: 3.390

7.  Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France.

Authors:  Paolo Bosetti; Cécile Tran Kiem; Yazdan Yazdanpanah; Arnaud Fontanet; Bruno Lina; Vittoria Colizza; Simon Cauchemez
Journal:  Euro Surveill       Date:  2021-01

8.  The impact of repeated mass antigen testing for COVID-19 on the prevalence of the disease.

Authors:  Martin Kahanec; Lukáš Lafférs; Bernhard Schmidpeter
Journal:  J Popul Econ       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.